Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile

Add time:09/03/2019    Source:sciencedirect.com

AimDesign and synthesis of novel nalidixic acid derivatives of potent anticancer and topoisomerase II inhibitory activities were our major aim.

We also recommend Trading Suppliers and Manufacturers of 3-(3-M-TOLYL-UREIDO)-PROPIONIC ACID (cas 133115-50-1). Pls Click Website Link as below: cas 133115-50-1 suppliers

Prev:1,3-Dithiol-2-ylidene derivatives of 1,3-indanedione
Next:Structure–activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A1 adenosine receptor)